These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7706525)

  • 21. Aggregation of lipoprotein(a) to apolipoprotein A-I underlying HDL dysfunction as a major coronary risk factor.
    Onat A; Can G; Murat S; Ciçek G; Örnek E; Yüksel H
    Anadolu Kardiyol Derg; 2013 Sep; 13(6):543-51. PubMed ID: 23835300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
    Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
    Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of lipoprotein(a) in patients with ischemic heart disease].
    Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
    J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism.
    Konerman M; Kulkarni K; Toth PP; Jones SR
    J Clin Lipidol; 2012; 6(1):27-32. PubMed ID: 22264571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects.
    Lecerf JM; Masson A; Fruchart JC; Bard JM
    Diabetes Metab; 1996 Oct; 22(5):331-40. PubMed ID: 8896995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A four-year prospective study on the influence of serum elevated lipoprotein (a) concentration on ischemic heart disease and cerebral infarction in elderly patients with type 2 diabetes].
    Suzuki T; Oba K; Igari Y; Matsumura N; Inuzuka Y; Kigawa Y; Ajiro Y; Okazaki K; Nakano H; Metori S
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):507-13. PubMed ID: 11523163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a): an independent risk factor for ischemic heart disease that is dependent on triglycerides in subjects with type 2 diabetes mellitus.
    Albahrani A; Alkindi M; Marks E; Alyahyaee S; Shenkin A
    Lipids Health Dis; 2007 Oct; 6():26. PubMed ID: 17908332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lp(a) levels in patients undergoing aorto-coronary bypass surgery.
    Averna MR; Barbagallo CM; Ocello S; Doria O; Davì G; Scafidi V; Albiero R; Notarbartolo A
    Eur Heart J; 1992 Oct; 13(10):1405-9. PubMed ID: 1396816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.
    Watts GF; Kearney EM; Taub NA; Slavin BM
    J Clin Pathol; 1993 Mar; 46(3):267-70. PubMed ID: 8463422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum LpAI lipoprotein particles in diabetic patients with and without renal lesions of different grades.
    Peynet J; Guillausseau PJ; Legrand A; Altman JJ; Flourie F; Chanson P; Poupon J; N'Guyen M; Warnet A; Lubetzki J
    Diabete Metab; 1993; 19(4):355-60. PubMed ID: 8293861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus.
    Contiero E; Ferrari R; Vaselli GM; Folin M
    Diabetes Res Clin Pract; 1998 Mar; 39(3):201-9. PubMed ID: 9649952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of serum lipoproteins after coronary artery bypass surgery.
    Shaukat N; Ashraf SS; Mackness MI; Mbewu AD; Bhatnagar D; Durrington PN
    QJM; 1994 Sep; 87(9):539-45. PubMed ID: 7953502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.
    Sewdarsen M; Desai RK; Vythilingum S; Shah N; Rajput MC
    Postgrad Med J; 1991 Feb; 67(784):159-64. PubMed ID: 2041847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipoprotein (a) levels in men with peripheral vascular disease.
    Nogués X; Sentí M; Pedro-Botet J; Rubiés-Prat J; Vidal-Barraquer F
    Angiology; 1991 Aug; 42(8):659-64. PubMed ID: 1832526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoproteins and ischaemic heart disease: implications for screening.
    Wald NJ; Law M; Watt HC; Wu T; Bailey A; Johnson AM; Craig WY; Ledue TB; Haddow JE
    Lancet; 1994 Jan; 343(8889):75-9. PubMed ID: 7903777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.